Quotient Limited Announces Pricing of Underwritten Offering

JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 66,666,667 ordinary shares and ordinary share equivalents for aggregate gross proceeds of $20.0 million. The aggregate net proceeds to the Company from this offering are expected to be approximately $18.5 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. All of the securities sold in the offering were offered by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 10,000,000 of its ordinary shares. The offering is expected to close on June 28^th, 2022, subject to customary closing conditions.